Company Profile
Updated: 06-NOV-09Intercell AG
International public company
Campus Vienna Biocenter 6, Wien, A-1030, Austria
()43 01 206 20 0, 43 01 206 20 800 fax, http://www.intercell.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Research and development of vaccines for the prevention and treatment of infectious diseases
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Novartis: - A Detailed And Comprehensive Overview Of Current Financial Position, Company Strategy, Product And Pipeline Analysis.
M2 Presswire; 12/3/2009; 1396 words; ...Medsystems Inc - Cytos Biotechnology AG - Cytopia Ltd - Dynavax Technologies...Incorporated - Infinity Pharmaceuticals Inc - Intercell AG - IVAX Corporation - Kyorin Pharmaceutical...Pharmaceuticals Inc (MIP) - MorphoSys AG - NexMed Inc - Ono Pharmaceutical Co...
RCB lowers Intercell price target to EUR 27.70.
ADP News Austria; 11/20/2009; 404 words; ...stock of Austrian vaccine developer Intercell AG (WBAG:ICLL) to EUR 27.70...for the target downgrade was that Intercell lowered its sales and profit forecast...vaccine. At 1615 CET on Friday Intercell was trading up 0.87% at EUR...
Researchers at Intercell AG publish new data on immunization.
Vaccine Weekly; 11/18/2009; 776 words; ...wrote A. Fritzer and colleagues, Intercell AG (see also Immunization). The...information, contact A.L. Meinke, Intercell AG, Campus Vienna Bioctr 3, A...Streptococcal, Streptococcus, Intercell AG. This article was prepared by...
Erste Group cuts Austrian Intercell target to EUR 31.70.
ADP News Austria; 11/17/2009; 434 words; ...target on Austrian vaccine developer Intercell AG (WBAG:ICLL) to EUR 31.70...opportunity for investors to buy into Intercell. Therefore she retained her...On the Vienna Stock Exchange, Intercell had inched up 0.12% to EUR 24...
Austrian Intercell net loss more than doubles in Q3 2009.(Financial report)
ADP News Austria; 11/9/2009; 574 words; ...ADPnews) - Nov 9, 2009 - Austrian vaccine developer Intercell AG (WBAG:ICLL) had to take a hard blow in the third...million a year ago. For the first nine months of 2009, Intercell posted a net loss of EUR 25.93 million, after a loss...
Recent News Articles
- Intercell AG Joins OTCQX.
PR Newswire - August 10, 2009 - Researchers' work from Intercell AG focuses on west nile virus.
Biotech Week - July 15, 2009 - Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS).
PR Newswire - May 28, 2009 - The Bank of New York Mellon Appointed Depositary Bank by Intercell AG.
PR Newswire - May 11, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning